Steris (STE) said Tuesday that a jury trial since December against its Isomedix Operations unit ended in a mistrial on Friday and the court will schedule the case for re-trial.
The mistrial was declared at plaintiff's request during jury deliberations after a juror was dismissed, reducing the jury to fewer than 12 people, the company said.
The case involves allegations by an individual plaintiff that ethylene oxide emissions from a sterilization plant owned and operated by Isomedix from 2005 to 2008 in Waukegan, Illinois, caused personal injury, Steris said.
Shares of Steris were up more than 3% in early trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。